ReviewJournal of exposure science & environmental epidemiology2026
Relevance and implementation of human biomonitoring to assess the chemical exposures following an industrial accident.
Review in Journal of exposure science & environmental epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAfter an industrial accident, workers at the site of the accident, as well as workers from nearby companies and responders (such as firefighters and police officers), and the surrounding population could be exposed to hazardous chemicals. In these situations, human biomonitoring measures are required by the population to assess the impact of the accident. However, HBM studies are usually conducted to assess the chronic exposure of chemicals for the general population, and no frame exists to apply these measures to such accidental context.
objectiveFollowing a major industrial fire that occurred in Normandy in 2019, Santé publique France established a framework for HBM measurements following an industrial accident, in order to assess the relevance of such measurements and give operational guidelines to carry out these measures, from the sampling to the interpretation of the measures, in support to policy makers and health professionals.
methodsA bibliographic search on HBM protocols in case of accidents and HBM studies already implemented worldwide following an accident was conducted as well as numerous consultations covering scientific aspects, ethical and deontological considerations, and practical aspects of implementing an HBM protocol in the event of an accident.
resultsThe HBM framework designed includes an initial HBM phase within 48 h following the end of emissions from the accident. Given the short deadlines for this first phase, it is advisable to target the most exposed and impacted individuals, that is, all persons (workers, occupants, emergency services, etc.) who were present on site during the industrial accident, as well as all individuals who visit a healthcare facility from the day of the accident until 48 h after the end of accidental emissions and for circumstances related to the accident. Sampling kits have to be quickly deployed in the event of an industrial accident requiring the implementation of HBM. Following this initial phase, medium- and long-term biological monitoring may be considered based on available information about the emitted chemicals and observed environmental contamination. IMPACT STATEMENT: The assessment of exposure to chemical substances through HBM after an accident requires the development of a standardized framework, particularly for chemicals with short half-lives. Exposure to chemical substances, after an accident, affects the general population residing near the accident site, as well as workers and emergency services.
Indexed as
Identifiers
42493587What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.